Annual Report 2024

Statement of changes in equity of medmix Ltd

thousands of CHF

 

Share capital

 

Reserves from capital contribution

 

Other capital reserves

 

Voluntary retained earnings

 

Treasury shares

 

Profit / (loss) brought forward

 

Profit / (loss) for the year

 

Total

Equity as of January 1, 2023

 

413

 

294’653

 

50’000

 

268’951

 

–12’470

 

4’045

 

14’270

 

619’862

Allocation of free reserves

 

 

 

 

 

 

 

–5’000

 

 

 

5’000

 

 

 

Dividend

 

 

 

 

 

 

 

 

 

 

 

–20’454

 

 

 

–20’454

Allocation of net income

 

 

 

 

 

 

 

 

 

 

 

14’270

 

–14’270

 

Profit / (loss) for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

33’552

 

33’552

Change in treasury shares

 

 

 

 

 

 

 

 

 

–2’714

 

 

 

 

 

–2’714

Equity as of December 31, 2023

 

413

 

294’653

 

50’000

 

263’951

 

–15’184

 

2’861

 

33’552

 

630’246

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2024

 

413

 

294’653

 

50’000

 

263’951

 

–15’184

 

2’861

 

33’552

 

630’246

Dividend

 

 

 

 

 

 

 

 

 

 

 

–20’388

 

 

 

–20’388

Allocation of net income

 

 

 

 

 

 

 

 

 

 

 

33’552

 

–33’552

 

Profit / (loss) for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

19’033

 

19’033

Change in treasury shares

 

 

 

 

 

 

 

 

 

636

 

 

 

 

 

636

Equity as of December 31, 2024

 

413

 

294’653

 

50’000

 

263’951

 

–14’548

 

16’025

 

19’033

 

629’526